Introduction
The disease is commonly known as:
“Valley Fever”
because it is endemic in desert valleys of:
- Southwestern United States
- Arizona
- California
- Mexico
- Central and South America

The infection primarily affects the lungs following inhalation of fungal spores. Although many infections remain asymptomatic or mild, severe pulmonary disease and disseminated systemic infection may occur in immunocompromised individuals.
Coccidioidomycosis is an important occupational disease among:
- Farmers
- Construction workers
- Archaeologists
- Military personnel
- Laboratory workers
Causative Organism
Coccidioides immitis and Coccidioides posadasii
Characteristics
- Dimorphic fungi
- Mold form in soil and culture
- Spherule form in tissues
- Highly infectious arthroconidia produced in environment
These fungi survive in:
- Dry alkaline soil
- Desert dust
- Hot climates
Morphology
1. Mold Form (Environmental Phase)
- Soil
- Laboratory culture at 25°C
Features
- Septate branching hyphae
- Barrel-shaped arthroconidia
- Empty disjunctor cells between arthroconidia
Infective Form
Arthroconidia
These spores easily become airborne and are inhaled into lungs.
2. Tissue Form
Characteristic Feature
Large thick-walled spherules filled with endospores
Size
- 20–80 µm diameter
When mature spherules rupture:
- Endospores are released
- New spherules develop
This process promotes spread of infection.
Pathogenesis
Infection occurs mainly through:
Inhalation of airborne arthroconidia
The spores are inhaled from:
- Contaminated dust
- Disturbed soil
- Construction sites
- Dust storms
Human-to-human transmission is extremely rare.
Mechanism of Infection
Stepwise Pathogenesis
- Inhalation of arthroconidia into lungs
- Transformation into spherules
- Multiplication of endospores
- Rupture of spherules
- Local pulmonary inflammation
- Granuloma formation
- Possible dissemination via blood and lymphatics
Host Immune Response
Cell-mediated immunity plays an important role in controlling infection.
Patients with impaired immunity are more susceptible to:
- Severe pulmonary disease
- Disseminated infection
Clinical Manifestations
Clinical severity depends on:
- Size of inoculum
- Immune status
- Extent of dissemination
1. Asymptomatic Infection
Many infected individuals remain asymptomatic.
The disease may be detected incidentally on:
- Chest X-ray
- Serological testing
2. Primary Pulmonary Coccidioidomycosis
Symptoms
- Fever
- Dry cough
- Chest pain
- Fatigue
- Dyspnea
- Headache
- Night sweats
Additional Features
- Arthralgia
- Myalgia
- Erythema nodosum
- Erythema multiforme
Pulmonary lesions may heal spontaneously.
3. Chronic Pulmonary Coccidioidomycosis
Occurs in some patients after primary infection.
Features
- Persistent cough
- Hemoptysis
- Weight loss
- Pulmonary cavities
- Fibrosis
May resemble:
- Tuberculosis
- Lung carcinoma
4. Disseminated Coccidioidomycosis
Risk Groups
- HIV/AIDS patients
- Organ transplant recipients
- Pregnant women
- Diabetics
- Immunosuppressed patients
Common Sites of Dissemination
- Skin
- Bones
- Joints
- Lymph nodes
- Meninges
Clinical Features
1. Asymptomatic Infection
Many infected individuals remain asymptomatic.
Features
- No obvious symptoms
- Detected incidentally on:
- Chest X-ray
- Serological testing
2. Primary Pulmonary Coccidioidomycosis
Symptoms
- Fever
- Dry cough
- Chest pain
- Fatigue
- Headache
- Dyspnea
- Night sweats
Additional Features
- Arthralgia
- Myalgia
- Erythema nodosum
- Erythema multiforme
Mild pulmonary disease may resolve spontaneously.
3. Chronic Pulmonary Coccidioidomycosis
Occurs in some patients after primary infection.
Features
- Persistent cough
- Hemoptysis
- Weight loss
- Pulmonary cavities
- Fibrosis
May clinically resemble:
- Tuberculosis
- Chronic lung disease
4. Disseminated Coccidioidomycosis
Common in:
- HIV/AIDS patients
- Immunocompromised individuals
- Pregnant women
Sites of Dissemination
A. Skin
- Nodules
- Ulcers
- Verrucous lesions
- Abscesses
B. Bones and Joints
- Osteomyelitis
- Arthritis
- Bone pain and swelling
C. Central Nervous System
Coccidioidal meningitis
- Severe headache
- Neck stiffness
- Vomiting
- Neurological deficits
This is one of the most serious complications.
D. Lymph Nodes
- Lymphadenopathy may occur.
Laboratory Diagnosis
Laboratory diagnosis of Coccidioidomycosis is based on clinical findings, microscopy, culture, histopathology, serology, and molecular methods. Identification of characteristic spherules with endospores is highly important for diagnosis.
1. Specimen Collection
The type of specimen depends on the site of infection.
Common specimens include:
- Sputum
- Bronchoalveolar lavage (BAL)
- Tissue biopsy
- Pus or exudate
- Pleural fluid
- Cerebrospinal fluid (CSF) in meningitis cases
Proper collection and handling are essential because the fungus is highly infectious in culture.
2. Direct Microscopic Examination
Features of Spherules
- Round structures
- Thick wall
- Filled with numerous endospores
- Size: 20–80 µm
When mature spherules rupture, endospores are released.
Stains Used
- Potassium hydroxide (KOH) mount
- PAS stain (Periodic acid–Schiff stain)
- Gomori methenamine silver (GMS) stain
These stains help visualize fungal structures in tissues.
3. Culture
Culture Medium
- Sabouraud dextrose agar (SDA)
Incubation
- Incubated at 25°C
Colony Characteristics
- White fluffy cotton-like colonies
- Later become grayish or tan

Microscopic Findings
- Septate hyphae
- Barrel-shaped arthroconidia alternating with empty disjunctor cells
Laboratory Hazard
Culture handling requires strict biosafety precautions because arthroconidia are highly infectious and may spread through air.
4. Histopathological Examination
Biopsy specimens may show:
- Granulomatous inflammation
- Giant cells
- Necrosis
- Spherules containing endospores
Special fungal stains help identify organisms clearly.
5. Serological Tests
Serology is widely used for diagnosis and monitoring.
Important Tests
- Complement fixation test
- Immunodiffusion test
- Enzyme immunoassay (EIA)
Uses
- Detection of antibodies
- Assessment of disease severity
- Monitoring treatment response
High antibody titers may indicate disseminated disease.
6. Molecular Diagnosis
PCR-Based Methods
Used in advanced laboratories for:
- Rapid diagnosis
- Species identification
- Confirmation of difficult cases
These methods are highly sensitive and specific.
Prevention
1. Avoid Exposure to Contaminated Dust
The fungus is commonly present in:
- Dry desert soil
- Dusty environments
- Construction and excavation sites
Avoid unnecessary exposure to:
- Dust storms
- Soil excavation
- Agricultural dust
2. Use Protective Respiratory Equipment
People working in endemic areas should wear:
- N95 masks
- Respirators
- Protective face coverings
Especially important for:
- Construction workers
- Farmers
- Archaeologists
- Military personnel
- Laboratory workers
3. Dust Control Measures
Measures to reduce airborne spores include:
- Wetting soil before excavation
- Dust suppression techniques
- Proper ventilation systems
These methods reduce inhalation of infectious arthroconidia.
4. Protection of High-Risk Individuals
High-risk groups should avoid exposure to contaminated environments.
High-risk individuals include:
- HIV/AIDS patients
- Organ transplant recipients
- Pregnant women
- Patients on immunosuppressive therapy
5. Laboratory Safety
Culture handling should be performed in:
- Biosafety cabinets
- Specialized laboratories
Because arthroconidia are highly infectious and may spread through air.
6. Early Diagnosis and Treatment
Early recognition of symptoms and prompt treatment help prevent:
- Chronic pulmonary disease
- Disseminated infection
- Serious complications such as meningitis
